SCHEMBL22309550

SCHEMBL22309550

CC1(C)c2ccccc2-c2ccc(-c3nc(-c4ccccc4)cc(-c4cccc(-c5cccc(-c6nc(-c7cccc8ccccc78)nc(-c7cccc8ccccc78)n6)c5)c4)n3)cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
ALDH1A1 P00352 5/20 0.40
HPGD P15428 5/20 0.40
MAPT P10636 4/20 0.40
KDM4E B2RXH2 4/20 0.40
LMNA P02545 2/20 0.40
GLA P06280 1/20 0.40
PDK2 Q15119 7/20 0.37
NTSR1 P30989 1/20 0.36
ENPP3 O14638 1/20 0.36
ENPP1 P22413 1/20 0.36
TSHR P16473 2/20 0.35
MAPK1 P28482 2/20 0.35
ATM Q13315 2/20 0.35
HSD17B10 Q99714 2/20 0.35
TP53 P04637 1/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22308667 0.98 ALDH1A1 (0.40) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL24255977 0.94 ALDH1A1 (0.40) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL27101104 0.93 MEN1 (0.40) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL22309508 0.93 MEN1 (0.40) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL24453365 0.93 PDK2 (0.40) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL22309350 0.92 MEN1 (0.42) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17151892 0.92 ENPP3 (0.38) ALDH1A1HPGDMAPTKDM4EPDK2
SCHEMBL22309000 0.92 MEN1 (0.47) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL22308985 0.91 ALDH1A1 (0.41) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25533592 0.91 ENPP3 (0.38) MEN1KMT2AALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917910-B2 Organic compound and organic electroluminescent device using the same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2024-02-27 US disclosed
US-11917910-B2 Organic compound and organic electroluminescent device using the same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2024-02-27 US disclosed
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOOSAN CORPORATION (KR) 2020-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME VDAC1, OR10J3, PIEZO1 MEN1 2484/4885KMT2A 2549/4885ALDH1A1 644/4885
US-11917910-B2 Organic compound and organic electroluminescent device using the same VDAC1, OR10J3, PIEZO1 MEN1 2484/4885KMT2A 2549/4885ALDH1A1 644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.